EXPERIENŢA CLINICII DE BOLI INFECŢIOASE – IASI ÎN INFECŢIILE FUNGICE SEVERE LA PERSOANELE FĂRĂ INFECŢIE HIV (STUDIU PE O PERIOADĂ DE PATRU ANI)

July 1, 2008

Andra Teodor, Laura Ghibu, Carmen Dorobăţ, D. Teodor, Codrina Bejan, V. Luca
Clinica de Boli Infecţioase – Iaşi

Abstract

OBJECTIF – To evaluated clinical and ethyological aspects, diagnosis and treatment possibilities at patients hospitalised with severe fungal infections in Clinic of Infectious Diseases – Iasi. MATERIAL AND METHODS – Retrospectiv study between 2004 – 2007 included all patients with severe fungal infection admitted in Clinic of Infectious Diseases. RESULTS – 29 patients (median age – 65 years). Risk factors for invasive fungal infection were: associated clinical entities (neurological pathologies – 14, renal failure – 6, diabetis – 4, cirrosis – 3, respiratory conditions – 2, pancitopeny – 2) and medical procedures (urinary catheter – 19, central intravenous catheter – 3, hemodialysis – 3). Fungal species were isolated from uroculture – 19, hemoculture – 5, culture of tracheal aspirate – 5.The most frequent specie was Candida albicans – 18 cases. In 4 cases of sepsis, Candida was associated with S. aureus. Antifungal testing identified resistance at Flucitosine (1 case) and intermediary susceptibility at Itraconasol (1 case). Fluconasol was preffered in therapy – 17 cases. In evolution 6 deces. CONCLUSIONS – Severe fungal infection has an increasing incidence in our hospital in the same time with increasing risk. We didn’t observe significant changes in ethiology and antifungal susceptibility.

Previous Story

PATOLOGIA EXTREMĂ ASOCIATĂ CANICULEI

Next Story

SEPSIS SEVER CU MRSA LA O PACIENTĂ IMUNODEPRIMATĂ PRIN LES ŞI CORTICOTERAPIE. ROLUL METASTAZELOR SEPTICE OSOASE ÎN STABILIREA UNEI DURATE ADECVATE A ANTIBIOTICOTERAPIEI